电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Suppression of Tumorigenicity 14 (Colon Carcinoma) 抗体

(Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14))
The protein encoded by this gene is an epithelial-derived, integral membrane serine protease. This protease forms a complex with the Kunitz-type serine protease inhibitor, HAI-1, and is found to be activated by sphingosine 1-phosphate. This protease has been shown to cleave and activate hepatocyte growth factor/scattering factor, and urokinase plasminogen activator, which suggest the function of this protease as an epithelial membrane activator for other proteases and latent growth factors. The expression of this protease has been associated with breast, colon, prostate, and ovarian tumors, which implicates its role in cancer invasion, and metastasis. [provided by RefSeq, Jul 2008].
ST14 抗体  (AA 11-100) ST14 抗体  (AA 11-100) ST14 抗体 (AA 11-100) (ABIN669726)

ST14 适用: 人 WB, ELISA, IHC (p), IF (cc), IF (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated

ST14 抗体  (Internal Region) ST14 抗体  (Internal Region) ST14 抗体 (Internal Region) (ABIN6263143)

ST14 适用: 人, 小鼠 WB, ELISA, IHC, IF, ICC 宿主: 兔 Polyclonal unconjugated

ST14 抗体 ST14 抗体 ST14 抗体 (ABIN632186)

ST14 适用: 人, 小鼠, 大鼠 WB, IHC 宿主: 兔 Polyclonal unconjugated

Suppression of Tumorigenicity 14 (Colon Carcinoma) 抗体 by 适用

Find Suppression of Tumorigenicity 14 (Colon Carcinoma) 抗体 for a variety of species such as anti-Human Suppression of Tumorigenicity 14 (Colon Carcinoma), anti-Mouse Suppression of Tumorigenicity 14 (Colon Carcinoma), anti-Rat Suppression of Tumorigenicity 14 (Colon Carcinoma). The species listed below are among those available. Click on a link to go to the corresponding products.

Suppression of Tumorigenicity 14 (Colon Carcinoma) 抗体 by 应用范围

Find Suppression of Tumorigenicity 14 (Colon Carcinoma) 抗体 validated for a specific application such as WB, ELISA, IHC, IF. Some of the available applications are listed below. Click on a link to go to the corresponding products.

Suppression of Tumorigenicity 14 (Colon Carcinoma) 抗体 by 抗体来源

Find Suppression of Tumorigenicity 14 (Colon Carcinoma) 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.

Suppression of Tumorigenicity 14 (Colon Carcinoma) 抗体 by 抗原表位

Find Suppression of Tumorigenicity 14 (Colon Carcinoma) 抗体 with a specific epitope. The epitopes listed below are among those available. Click on a link to go to the corresponding products.

Suppression of Tumorigenicity 14 (Colon Carcinoma) 抗体 by 克隆形成能力

Find available monoclonal or polyclonal Suppression of Tumorigenicity 14 (Colon Carcinoma) 抗体. Click on a link to go to the corresponding products.

Suppression of Tumorigenicity 14 (Colon Carcinoma) 抗体 by 克隆

Find Suppression of Tumorigenicity 14 (Colon Carcinoma) 抗体 with a specific 克隆. The 克隆 listed below are among those available. Click on a link to go to the corresponding products.

Suppression of Tumorigenicity 14 (Colon Carcinoma) 抗体 by 标记

Find Suppression of Tumorigenicity 14 (Colon Carcinoma) 抗体 with a specific conjugate such as Biotin, FITC, APC. The conjugates listed below are among those available. Click on a link to go to the corresponding products.

Popular Suppression of Tumorigenicity 14 (Colon Carcinoma) 抗体

Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity Human
Application WB, ELISA, IHC (p), IF (cc), IF (p), IHC (fro)
Validations
  • (4)
Cat. No. ABIN669726
Quantity 100 μL
Datasheet Datasheet
Reactivity Human, Mouse
Application WB, ELISA, IHC, IF, ICC
Validations
  • (3)
Cat. No. ABIN6263143
Quantity 100 μL
Datasheet Datasheet
Reactivity Human, Mouse, Rat
Application WB, IHC
Validations
  • (3)
Cat. No. ABIN632186
Quantity 100 μL
Datasheet Datasheet
Reactivity Cow, Dog, Guinea Pig, Horse, Human, Mouse, Pig, Rabbit, Rat
Application WB, IHC
Validations
  • (1)
  • (3)
Cat. No. ABIN2773910
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application WB, IF, IHC (p), EIA
Validations
  • (4)
Cat. No. ABIN615862
Quantity 50 μg
Datasheet Datasheet
Reactivity Human, Mouse
Application ELISA, IHC
Validations
  • (2)
Cat. No. ABIN7235293
Quantity 200 μL
Datasheet Datasheet
Reactivity Human
Application ELISA
Validations
  • (1)
  • (1)
Cat. No. ABIN520529
Quantity 100 μg
Datasheet Datasheet
Reactivity Human
Application WB, ELISA, IHC, IF, IHC (p)
Validations
  • (2)
Cat. No. ABIN2878727
Quantity 50 μL
Datasheet Datasheet
Reactivity Human, Mouse
Application WB, IHC (p)
Validations
  • (3)
Cat. No. ABIN652185
Quantity 400 μL
Datasheet Datasheet
Reactivity Human
Application WB, ELISA, IF
Validations
  • (1)
Cat. No. ABIN7188865
Quantity 100 μg
Datasheet Datasheet
Reactivity Human
Application ELISA, IHC
Validations
  • (1)
Cat. No. ABIN7171018
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application WB, ELISA
Validations
  • (1)
Cat. No. ABIN563019
Quantity 50 μL
Datasheet Datasheet
Reactivity Cow, Guinea Pig, Horse, Human, Rat
Application WB
Validations
  • (1)
Cat. No. ABIN6744844
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application WB
Validations
  • (1)
Cat. No. ABIN6148517
Quantity 100 μL
Datasheet Datasheet

Application WB
Validations
  • (2)
Cat. No. ABIN2783208
Quantity 100 μL
Datasheet Datasheet

Latest Publications for our Suppression of Tumorigenicity 14 (Colon Carcinoma) 抗体

Landova Sulcova, Zahradnicek, Dumkova, Dosedelova, Krivanek, Hampl, Kavkova, Zikmund, Gregorovicova, Sedmera, Kaiser, Tucker, Buchtova: "Developmental mechanisms driving complex tooth shape in reptiles." in: Developmental dynamics : an official publication of the American Association of Anatomists, Vol. 249, Issue 4, pp. 441-464, (2020) (PubMed).

Drees, Königsmann, Jaspers, Pflanz, Riedel, Schuh: "Conserved function of the matriptase-prostasin proteolytic cascade during epithelial morphogenesis." in: PLoS genetics, Vol. 15, Issue 1, pp. e1007882, (2019) (PubMed).

Buzza, Johnson, Conway, Martin, Mukhopadhyay, Shea-Donohue, Antalis: "Inflammatory cytokines down-regulate the barrier-protective prostasin-matriptase proteolytic cascade early in experimental colitis." in: The Journal of biological chemistry, Vol. 292, Issue 26, pp. 10801-10812, (2017) (PubMed).

Friis, Tadeo, Le-Gall, Jürgensen, Sales, Camerer, Bugge: "Matriptase zymogen supports epithelial development, homeostasis and regeneration." in: BMC biology, Vol. 15, Issue 1, pp. 46, (2017) (PubMed).

Friis, Madsen, Bugge: "Distinct Developmental Functions of Prostasin (CAP1/PRSS8) Zymogen and Activated Prostasin." in: The Journal of biological chemistry, Vol. 291, Issue 6, pp. 2577-82, (2016) (PubMed).

Zoratti, Tanabe, Varela, Murray, Bergum, Colombo, Lang, Molinolo, Leduc, Marsault, Boerner, List: "Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling." in: Nature communications, Vol. 6, pp. 6776, (2015) (PubMed).

Sales, Friis, Abusleme, Moutsopoulos, Bugge: "Matriptase promotes inflammatory cell accumulation and progression of established epidermal tumors." in: Oncogene, Vol. 34, Issue 35, pp. 4664-72, (2015) (PubMed).

Hwang, Kim, Min, Raghunathan, Panova, Munshi, Ryu: "Epigenetic Silencing of SPINT2 Promotes Cancer Cell Motility via HGF-MET Pathway Activation in Melanoma." in: The Journal of investigative dermatology, Vol. 135, Issue 9, pp. 2283-91, (2015) (PubMed).

Szabo, Peters, Kosa, Camerer, Bugge: "Regulation of feto-maternal barrier by matriptase- and PAR-2-mediated signaling is required for placental morphogenesis and mouse embryonic survival." in: PLoS genetics, Vol. 10, Issue 7, pp. e1004470, (2015) (PubMed).

Beaulieu, Gravel, Cloutier, Marois, Colombo, Désilets, Verreault, Leduc, Marsault, Richter: "Matriptase proteolytically activates influenza virus and promotes multicycle replication in the human airway epithelium." in: Journal of virology, Vol. 87, Issue 8, pp. 4237-51, (2013) (PubMed).

Aliases for Suppression of Tumorigenicity 14 (Colon Carcinoma) 抗体

suppression of tumorigenicity 14 (ST14) 抗体
suppression of tumorigenicity 14 L homeolog (st14.L) 抗体
suppression of tumorigenicity 14 (colon carcinoma) (St14) 抗体
suppression of tumorigenicity 14 (St14) 抗体
suppression of tumorigenicity 14 (colon carcinoma) a (st14a) 抗体
suppression of tumorigenicity 14 (colon carcinoma) b (st14b) 抗体
suppression of tumorigenicity 14 S homeolog (st14.S) 抗体
Epithin 抗体
HAI 抗体
hai 抗体
matriptase 抗体
mCAP3 抗体
MT-SP1 抗体
mt-sp1 抗体
MTSP1 抗体
mtsp1 抗体
PRSS14 抗体
prss14 抗体
Prss14 抗体
SNC19 抗体
snc19 抗体
st14 抗体
st14-a 抗体
st14-b 抗体
st14a 抗体
st14b 抗体
TADG15 抗体
tadg15 抗体
tmprss1 抗体
TMPRSS14 抗体
Tmprss14 抗体
wu:fi41g07 抗体
wu:fl72f01 抗体
XMT-SP1 抗体
zgc:136950 抗体
zgc:152656 抗体
zgc:152657 抗体
zgc:152947 抗体
You are here:
客服